Back | Next |
home / stock / rdgl / rdgl message board
Subject | By | Source | When |
---|---|---|---|
But it isn't much of drop . I'll | lovethatgreen | investorshub | 07/01/2024 1:55:42 PM |
Ignorance and lack of exposure | lovethatgreen | investorshub | 07/01/2024 1:53:38 PM |
Amateur Hour.. | den4 | investorshub | 07/01/2024 1:53:29 PM |
Could anyone explain why the stock is falling? | PioneerEmpire67 | investorshub | 07/01/2024 1:51:51 PM |
27 days now | Tiger Money | investorshub | 07/01/2024 1:51:27 PM |
The Reg A-1 filingVIVOS INC (Form: 1-A, Received: | wrinklesobw | investorshub | 07/01/2024 11:55:51 AM |
Nice, thorough articleone good to pass along to | Bellionaire | investorshub | 07/01/2024 11:46:49 AM |
This will help you in thr future. | WALLnut | investorshub | 07/01/2024 10:27:36 AM |
Hi.. so, you were in PVDG/$VXIT back then?? | Bigfootbud | investorshub | 07/01/2024 6:33:35 AM |
IDE submitted on time. FDA decision due in | nathanial | investorshub | 07/01/2024 2:05:44 AM |
From thr FDA: An IDE application is considered | mc73 | investorshub | 07/01/2024 1:57:28 AM |
To add some color to your response, this | mc73 | investorshub | 07/01/2024 1:57:03 AM |
The submission was on Friday . Company said | doccjc | investorshub | 07/01/2024 1:53:32 AM |
Can anyone update me as to where we | myjog | investorshub | 07/01/2024 1:45:45 AM |
Ill take that and I agree. It should | Jrossco | investorshub | 06/30/2024 11:57:00 PM |
With a short week probably in the consolidation | nathanial | investorshub | 06/30/2024 11:46:00 PM |
Great informational Post Mc73. All shareholders can clearly | 1hunglo | investorshub | 06/30/2024 7:41:39 PM |
Yes it will be posted there but first | WALLnut | investorshub | 06/30/2024 7:17:55 PM |
Medical Devices Cleared or Approved by FDA in 2024 | Bigfootbud | investorshub | 06/30/2024 6:22:02 PM |
FDA IDE approval process:https://www.fda.gov/medical-devices/investigational-dev | mc73 | investorshub | 06/30/2024 6:00:23 PM |
News, Short Squeeze, Breakout and More Instantly...
--News Direct-- By Meg Flippin, Benzinga In what could prove to be a transformational development in cancer treatment, Vivos (OTCQB: RDGL), the maker of the Radiogel™ Precision Radionuclide Therapy, submitted an application to the U.S. Food and Drug Administration (FDA) to init...
Richland WA, June 28, 2024 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc. filed the application for an Investigational Device Exemption (“IDE”). The filing was an amendment, addressing the FDA comments to our previous application (Q211938/S001). Today’...
Lendway Inc. (LDWY) is expected to report for quarter end 2023-12-31 Hongchang International Co Ltd Com (New) (HCIL) is expected to report for Q4 2023 BioStem Technologies Inc (BSEM) is expected to report $0.47 for Q4 2023 Nicox SA (NICXF) is expected to report $-0.07 for Q4 2023 ...